These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12442394)

  • 21. Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated?
    Quaglio G; Lugoboni F; Vento S; Lechi A; Accordini A; Bossi C; Faccini M; Mecenero V; Pani A; Pantalena M; Residori M; Mezzelani P
    Clin Infect Dis; 2001 May; 32(10):E143-4. PubMed ID: 11317267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Delta hepatitis as a mixed infection].
    Fedorchenko SV; Vovk AD; Vozianova SV
    Vrach Delo; 1990 Mar; (3):5-8. PubMed ID: 2195767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccination in persons with isolated hepatitis B core antibodies.
    Liesnard CA
    Clin Infect Dis; 1999 Apr; 28(4):932-3. PubMed ID: 10825079
    [No Abstract]   [Full Text] [Related]  

  • 24. [HBe antigen and HBe antibody].
    Arase Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():124-8. PubMed ID: 15453300
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 28. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
    Avettand-Fenoel V; Thabut D; Katlama C; Poynard T; Thibault V
    J Clin Microbiol; 2006 Jun; 44(6):2250-3. PubMed ID: 16757632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin M hepatitis B core antibody: to titer or not to titer? to use or not to use?
    Gitnick G
    Gastroenterology; 1983 Mar; 84(3):653-5. PubMed ID: 6822334
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B virus infection in the school milieu of Kiffa and Selibaby, Mauritania].
    Rui WZ; Lo Baïdy B; N'Diaye M
    Bull Soc Pathol Exot; 1998; 91(3):247-8. PubMed ID: 9773202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between hepatitis B virus markers and quantitative HBV DNA in serum].
    Huang ZX; Chen DY; Zhang QB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):43. PubMed ID: 14761284
    [No Abstract]   [Full Text] [Related]  

  • 37. [The efficacy of the prevaccinal detection of anti-HBc in hepatitis B vaccination programs].
    Guarga Rojas A; Grifell Martín E
    Med Clin (Barc); 1993 Nov; 101(17):679. PubMed ID: 8289519
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of markers for human immunodeficiency, hepatitis B and hepatitis C viruses in maxillofacial and oral surgery patients at Medunsa.
    Dreyer AF; Aspinall S; Jacobs FJ
    J Dent Assoc S Afr; 1993 Jul; 48(7):377-80. PubMed ID: 9511617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis.
    Shimizu M; Ohyama M; Takahashi Y; Udo K; Kojima M; Kametani M; Tsuda F; Takai E; Miyakawa Y; Mayumi M
    Gastroenterology; 1983 Mar; 84(3):604-10. PubMed ID: 6822328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.